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Abstract: Tryptophan and arginine-rich cyclic hexapeptides of the type cyclo-RRRWFW 
combine high antibacterial activity with rapid cell killing kinetics, but show low toxicity in 
human cell lines. The peptides fulfil the structural requirements for membrane interaction 
such as high amphipathicity and cationic charge, but membrane permeabilisation, which is 
the most common mode of action of antimicrobial peptides (AMPs), could not be 
observed. Our current studies focus on elucidating a putative membrane translocation 
mechanism whereupon the peptides might interfere with intracellular processes. These 
investigations require particular analytical tools: fluorescent analogues and peptides 
bearing appropriate reactive groups were synthesized and characterized in order to be used 
in confocal laser scanning microscopy and HPLC analysis. We found that minimal changes 
in both the cationic and hydrophobic domain of the peptides in most cases led to significant 
reduction of antimicrobial activity and/or changes in the mode of action. However, we 
were able to identify two modified peptides which exhibited properties similar to those of 
the cyclic parent hexapeptide and are suitable for subsequent studies on membrane 
translocation and uptake into bacterial cells. 
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1. Introduction 
Antimicrobial peptides (AMPs) are ubiquitous defence molecules in organisms and have been shown 
to exhibit promising potential as a new class of antibiotics [1]. Among the structurally diverse AMPs, 
short sequences rich in arginine (R) and tryptophan (W) are of particular interest as cationic charge and 
amphipathicity represent the structural prerequisite for an initial electrostatic interaction of the peptide 
with negatively charged lipid systems and subsequent insertion into the lipid membrane [2]. 
The most common antimicrobial mechanism of action can be described by different models of 
membrane permeabilisation. Here, interaction with the lipid bilayer results in loss of membrane 
integrity, e.g., by pore formation, but also detergent-like peptide properties have been reported [3].  
In recent years, research on antimicrobial activity has led to the conclusion that there are also some 
cases where membrane permeabilisation is neither the only nor the dominating mode of action [4,5]. 
Translocation of AMPs into the cytoplasm could be observed, where the peptides interfere with 
cellular processes, such as protein synthesis and DNA replication. In addition, growing evidence 
suggests peptide interaction also with functional domains within the membrane which might result in 
lipid demixing and altered protein activity [6]. 
We could show that the synthetic cyclic hexapeptide cWFW with the sequence c-RRRWFW has an 
increased antibacterial activity against Gram-positive and Gram-negative bacteria compared to the 
linear sequence, while no toxicity towards eukaryotic cells could be detected [7]. Despite its 
pronounced antimicrobial potential, investigations on the mechanism of action revealed that cWFW 
does not act by the membrane permeabilisation mechanism generally associated with AMPs [8]. 
Recent studies of a set of K-/R- and W-rich linear peptides indicated that several of these compounds 
were able to penetrate the cell membrane of E. coli and to accumulate in the cytoplasm [9]. 
Furthermore, cyclisation-induced enhanced backbone rigidity has been suggested to increase the 
uptake efficiency of R-rich peptides for eukaryotic cells [10]. 
In order to examine putative translocation into the cytoplasm of bacterial cells, our hexapeptide had 
to be modified according to the requirements of the particular analytical techniques. For analysis with 
confocal laser scanning microscopy (CLSM) fluorescent analogues labeled with carboxyfluorescein 
(Fluos), coumarin (Cu) or nitrobenzoxadiazole (NBD) were synthesized. Furthermore, peptide uptake 
studies using an HPLC-based strategy developed by Oehlke et al. [11] required the introduction of free 
amino groups for chemical modification. 
In the present study we characterized the feasibility of the cyclic hexapeptide analogues for the 
above investigations by examining the consequences of peptide modification according to antibacterial 
activity and mechanism of action. 
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2. Experimental Section 
2.1. Materials 
Components for peptide synthesis were purchased/prepared as follows: Fmoc-Arg(Pbf)-OH,  
Fmoc-Lys(Boc)-OH, Fmoc-Trp(Boc)-OH (GL Biochem, Shanghai Ltd., Shanghai, China), Fmoc-L-
Dap(Dde)-OH (Iris Biotech, Marktredwitz, Germany), 4-Chloro-7-nitro-1,2,3-benzoxadiazole, (NBD-Cl, 
Sigma-Aldrich, St. Louis, MO, USA), 6-bromo-7-hydroxycoumarin-4-yl [12]. Chemical components 
for buffer preparation were purchased from Fluka (Taufkirchen, Germany). Triton X-100, EtOH and 
HCl came from Merck (Darmstadt, Germany). Materials for peptide characterisation were: E. coli 
DH5α, B. subtilis DSM 347, HeLa S (all from DSMZ, Braunschweig, Germany), human erythrocyte 
concentrate (Charité - Universitätsmedizin Berlin, Berlin, Germany), Gibco® Dulbecco’s Modified 
Eagle Medium (DMEM), Gibco® Dulbecco’s Phosphate Buffered Saline (DPBS), L-glutamine and 
penicillin-streptomycin (pen-strep) (all Life Technologies Corp., Darmstadt, Germany), fetal calf serum 
(FCS, Biochrom, Berlin, Germany), D-glucose (Sigma-Aldrich), lysogeny broth (LB, Sigma-Aldrich), 
nitroaniline (Sigma-Aldrich), 1-palmitoyl-2-oleoylphosphatidyl-sn-glycerol (POPG; Avanti Polar 
Lipids, Inc., Alabaster, AL, USA), polymyxin sulfate B (PMX, Fluka), propidium iodide (PI), sodium 
dodecyl sulfate (SDS) and sodium nitrite (all Sigma-Aldrich). Consumables used in cell culture were 
obtained from TPP (Trasadingen, Switzerland). FACS solutions came from Becton Dickinson 
(Heidelberg, Germany). For HPLC analysis: trifluoroacetic acid (TFA, Acros Organics, Geel, 
Belgium) and acetonitrile (VWR Chemicals, Darmstadt, Germany) were used. 
2.2. Peptide Synthesis 
The fluorescence-labeled peptides cW2[Fluos], cW3[Fluos] and cW[Cu]W (for sequences refer to 
(Table 1) were provided by Biosyntan (Berlin, Germany). The synthesis of the parent peptide cWFW 
and the lysine-containing analogues has been described previously [13]. Peptides were prepared by 
multiple solid phase synthesis using Fmoc/tBu strategy according to SHEPPARD [14]. Cleavage from 
resin and removal of protecting groups was done as described before [15], and cyclization was 
achieved manually by HAPyU chemistry [16]. Peptide purification and analysis were performed by 
high performance liquid chromatography (HPLC) on a Jasco LC-2000Plus (Tokyo, Japan) and Dionex 
UltiMate 3000 with ProntoSil 300-5-C18-H columns (250 × 4.6 mm, 5 µm) (Bischoff Chromatography, 
Leonberg, Germany). Peptide mass was determined by UPLC-MS (ultra-performance liquid 
chromatography mass spectrometry) on an ACQUITY UPLC® System by Waters (Milford, MA, USA) 
using an Ascentis® Express Peptide ES-C18 column (3 × 2.1 mm, 2.7 µm) (Sigma Aldrich). Final 
peptide purity was determined to be >95%. 
2.3. CD Spectroscopy 
Cyclic hexapeptides were dissolved to 100 µM in phosphate buffer (10 mM NaH2PO4/Na2HPO4, 
154 mM NaF, pH 7.4). To mimic a membrane-like environment, SDS or POPG SUVs (small 
unilamellar vesicles) were added to give final concentrations of 25 mM detergent and 10 mM lipid. 
Due to light scattering of liposomes, spectra could only be recorded down to 205 nm. Vesicle 
preparation has been described previously [17]. Dried POPG lipids were dissolved in phosphate buffer 
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and sonicated on ice for 20 min. CD spectra were obtained on a Jasco 720 spectrometer (Japan). Twenty 
scans were accumulated within the range of 260 nm and 190 nm using a 2 mm pathlength quartz cell. 
Results are presented as mean residue molar ellipticity Θmr. 
2.4. Hydrophobicity 
The retention time tR of the cyclic hexapeptides was determined by HPLC on a Jasco LC-2000Plus 
using a ProntoSil 300-5-C18-H column (250 × 4.6 mm, 5 µm) (Bischoff Chromatography). Peptide 
concentration was 1 mg/mL in mobile phase A (0.1% TFA in deionized water), mobile phase B 
consisted of 0.1% TFA in 80% acetonitrile in deionized water. For chromatographic analyses a linear 
gradient of 5%–95% phase B over 40 min at 22 °C was applied. 
2.5. Antimicrobial Activity 
The minimal inhibitory concentration (MIC) of the cyclic hexapeptides was tested against  
Gram-negative E. coli DH5α and Gram-positive B. subtilis DSM 347 using a microdilution technique 
in 96 well microtiter plates as described previously [18]. Briefly, cells from an overnight culture were 
inoculated 1:100 in LB medium, grown to mid log phase (OD600 0.4 ± 0.1) and adjusted to 5 × 105 
cells/well. Final peptide concentrations ranged from 0.05 µM to 100 µM (2-fold dilutions) and were 
tested in triplicates in at least three independent experiments. The MIC was determined after 18 h of 
incubation at 37 °C, 180 rpm being the lowest peptide concentration at which no visible bacterial 
growth can be detected photometrically (A600, Safire Microplate Reader, Tecan, Männedorf, Germany). 
2.6. Hemolytic Activity 
The lytic effect of selected peptides upon human erythrocytes was determined as described before [7]. 
Briefly, cells were washed thoroughly in Tris buffer (10 mM Tris, 150 mM NaCl, pH 7.4). Suspensions 
with 2.5 × 108 cells/mL were incubated with peptides at a final concentration of 100 µM for 30 min at 
37 °C. After centrifugation, 0.6% NH4OH was added to an aliquot of the supernatant and hemoglobin 
absorption (A) was measured at 540 nm (Jasco V-550). Whole cell suspensions exposed to NH4OH 
were used as positive control (A100%) and preparations without peptide served as negative control 
(A0%), respectively. Data were collected in three independent experiments. 
2.7. Propidium Iodide Influx 
Membrane permeabilisation was determined by fluorescence activated cell sorting (FACS) on a 
FACSCalibur (Becton Dickinson) equipped with a 488 nm argon laser. Propidium iodide (PI,  
10 µg/mL) and peptides at a final concentration corresponding to the respective MIC were dissolved in 
LB. Cells were grown to mid log phase (OD600 0.4 ± 0.1) and added to the solution just before the 
measurement at a concentration of 5 × 105 cells/mL. Cells were sorted on the basis of PI fluorescence 
which increases upon intercalation with DNA. This can only be observed in the case of disturbed 
membrane integrity as PI cannot translocate across intact lipid bilayers. Cell fluorescence was 
measured after incubation time points of 0, 5, 10, 15, 20, 30, 60 and 90 min at 37 °C, 180 rpm.  
A minimum of 20,000 cells was recorded for each preparation. CellQuestTM Pro software (Becton 
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Dickinson) was used for data acquisition and results were analyzed with FCS Express V3 (De Novo 
Software, Los Angeles, CA, USA). 
2.8. Cellular Uptake 
The applicability of chemically modified peptides in uptake experiments was tested with cR2[Cu] 
into HeLa S cells. The well characterized cell-penetrating peptide penetratin [19], here labeled with 
carboxyfluorescein (Fluos-penetratin), was used as positive control. HeLa S cells were cultivated in 
DMEM supplemented with 1 g/L D-glucose, 1% FCS and 1% pen-strep. For uptake experiments, cells 
were harvested and diluted to 1 × 106 cells/mL in PBS supplemented with 1 g/L D-glucose. Peptides 
were added at final concentrations of 18 µM (cR2[Cu]) and 9 µM (Fluos-penetratin), respectively, and 
cells were incubated at 37 °C for 1 h with careful shaking (Thermomixer Comfort, Eppendorf, 
Wesseling-Berzdorf, Germany). After centrifugation (1,500 × g, 4 min, 0 °C, Biofuge primoR, 
Heraeus, Bremen, Germany), the supernatant was removed and stored for subsequent HPLC studies to 
quantify peptide amount which has not been accumulated or internalized. Cells were washed twice 
with ice-cold PBS and finally resuspended in 0.5 mL ice-cold PBS. As described previously, 10 µL of 
a freshly prepared diazotized 2-nitroaniline solution was added and allowed to react for 10 min at 0 °C 
(ice bath) in order to modify membrane surface bound peptides [11,20]. After repeated washing with 
ice-cold PBS, cells were lysed with 500 µL 0.1% Triton X-100/0.1% TFA and stored at −20 °C until 
further use. Before HPLC analysis lysates were thawed at room temperature. BCATM Protein Assay 
Kit (Thermo Scientific, Bremen, Germany) was used for protein determination. The average protein 
content of the lysates of 106 cells was found to be 130 µg. Three independent experiments were 
performed in triplicate. 
The non-modified, translocated peptide was analysed by HPLC on a Jasco LC-2000Plus using a 
ProntoSil 300-5-C18-H column (250 × 4.6 mm, 5 µm) (Bischoff Chromatography) and a precolumn 
with PolyenCap A300, 10 µm. Up to 200 µL cell lysate were loaded onto the column. Peptide elution 
was realized with 0.1% TFA/deionized water (A) and 0.1% TFA in 80% acetonitrile/deionized water 
(B) at a flow rate of 1 mL/min and a gradient of 20%–70% B over 20 min. Quantification was 
performed by fluorescence measurement of carboxyfluorescein (ex 445 nm, em 520 nm) and 
methoxycoumarin (ex 350 nm, em 385 nm). Data were calibrated with standard solutions containing 
pure hexapeptide and Fluos-penetratin in 0.1% TFA (A) prepared under identical conditions. 
3. Results and Discussion 
3.1. Peptide Modifications and Antimicrobial Activity 
An overview of the antimicrobial peptides used in this study is given in Table 1. The cyclic hexapeptide 
cWFW served as template for the chemical modifications necessary for further peptide investigation. 
Confocal laser scanning microscopy (CLSM) requires the introduction of fluorescent labels  
(Figure 1). The successful application of carboxyfluorescein (Fluos)-labeled peptides in uptake  
studies is well documented [9,13,21]. Coumarin (Cu) and nitrobenzoxadiazole (NBD) were chosen  
due to their hydrophobic nature and structural similarity to tryptophan. The chemical derivatives 
methoxycoumarin and bromohydroxycoumarin (BHCM) differ in their fluorescence maxima with  
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396 nm and 468 nm, respectively. BHCM has been reported as photoactivatable protecting group with 
high quantum yield and increased solubility in aqueous solutions [12]. 
Figure 1. Chemical structures of cWFW and the four fluorescent labels used in this study. 
Fluorophores are depicted coupled to the respective amino acid (latter given in brackets) 
used to introduce the labels into the peptide ring. 
 
The HPLC approach to investigate peptide translocation is based on the chemical modification  
of extracellular and surface-bound peptides by diazotized 2-nitroaniline [20]. After cell lysis,  
non-modified (internalized) and nitroaniline-exposed peptide moieties can be distinguished by HPLC 
separation. As the chemical modification reaction is restricted to free amino groups, arginine was 
substituted by lysine residues at different positions in the peptide ring. 
All peptides (except cKRK) were more active towards the Gram-positive B. subtilis than the  
Gram-negative E. coli, thus confirming the activity profile of this class of peptides [7,22,23]. However, 
all modifications applied to cWFW led to an overall reduction in antimicrobial activity (Table 1). The 
bulky carboxyfluorescein, introduced via a lysine linker into the hydrophobic (cW2[Fluos]) as well as 
polar domain (cW3[Fluos]), led to a loss in positive net charge compared to the parent peptide. Both, 
the large size of the Fluos-fluorophore, as well as the change in hydrophobicity and amphipathicity 
might be responsible for the pronounced loss of antimicrobial activity to a level which was not 
observed for any of the other fluorescent labeled peptides (Table 1). 
As small modifications at the central position of the hydrophobic WFW cluster were shown to 
exhibit the least influence on antimicrobial activity [8], coumarin and NBD were introduced to 
substitute phenylalanine in order to maintain the overall amphipathic character of the molecule. 
Nevertheless, both labels also reduced peptide antimicrobial activity and in most cases led to an 
increase in hemolytic activity. Structural differences between the coumarin derivatives generally did 
not influence the antibacterial effect of cW[Cu]W and cW[S-Cu]W. 
The decrease in antibacterial activity observed after substitution of arginine residues with lysine in 
the polar cluster of the cyclic hexapeptides was slightly more pronounced compared to the decrease in 
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activity found for the fluorescent labeled peptides (excluding the Fluos-labeled peptides) (Table 1). Of 
the lysine-containing peptides, cKRK showed the best antibacterial potential. One arginine located in 
the centre of the cationic sequence motif seems to be highly important for optimal peptide interaction 
with bacterial membranes. The K-analogue cRKK exhibited significant hemolytic activity. 
The peptides cR2[Cu], cR2[S-Cu] and cR2[NBD] were synthesized to combine the high activity of 
cKRK with the best antibacterial properties found for the fluorescent analogues. The combination of 
both modifications had no additional negative influence on antimicrobial activity and kept the 
hemolytic activity low (Table 1). The most active peptides against the two bacterial strains bearing a 
fluorophore and two chemically reactive amino groups were cR2[Cu] and cR2[NBD]. To confirm if 
these analogues are suitable candidates for membrane translocation studies, the structural character and 
interaction with model membranes were determined and compared with that of the parent hexapeptide. 
Table 1. Sequences, antimicrobial and hemolytic activity of the cylic hexapeptide 
analogues. Minimal inhibitory peptide concentrations (MIC) were determined in triplicates 
in at least three independent experiments. Hemolytic activity was determined as % hemolysis 
at a peptide concentration of 100 µM. 
Peptides Sequences 
MIC [µM] 
Hemolysis [%] 
at 100 µM E. coli 
DH5α 
B. subtilis 
DSM 347 
cWFW c-RRRWFW 3 3 4 
cW2[Fluos] c-RRRWWK[Fluos] >100 >100 9 
cW3[Fluos] c-RRWWWK[Fluos] >100 >100 2 
cW[Cu]W c-RRRW[Ala-Coumarin]W 25 6 23 
cW[S-Cu]W c-RRRW[Cys-Br-Coumarin]W 25 6 76 
cW[NBD]W c-RRRW[Dap-NBD]W 50 25 76 
cRKR c-RKRWFW 50 12 4 
cRKK c-RKKWFW 50 25 56 
cKRK c-KRKWFW 12 25 2 
cKKR c-KKRWFW 100 25 3 
cKKK c-KKKWFW 100 50 8 
cR2[Cu] c-KRKW[Ala-Coumarin]W 50 6 4 
cR2[S-Cu] c-KRKW[Cys-Br-Coumarin]W 50 25 5 
cR2[NBD] c-KRKW[Dap-NBD]W 50 12 26 
Cu—coumarin; Dap—diaminopropionic acid; Fluos—carboxyfluorescein; NBD—nitrobenzoxadiazole. 
3.2. Peptide Hydrophobicity and Conformation 
To investigate the influence of fluorescent label modification and amino acid substitution on the 
hydrophobicity/amphipathicity of the cyclic hexapeptide derivatives, we determined the retention time 
tR by reversed phase HPLC (Figure 2). The method monitors the retention of compounds by the 
hydrophobic HPLC stationary phase. Differences in tR reflect differences in the effective hydrophobicity 
of the molecule which is related to the intrinsic hydrophobicity of the individual residues and their 
ability to form hydrophobic domains for interaction with the HPLC matrix. At the same time, 
hydrophilic residues will locate at the opposite side of the molecule. Reduction in the size or positioning 
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of cationic residues next to the hydrophobic molecular surface area would reduce amphipathicity.  
tR-measurements have successfully been applied to characterize amphipathic helices [24], β-structured 
peptides [25] and different sets of our small cyclic R-, W-rich peptides [23,26,27]. 
The introduction of fluorophores generally increased retention time. This can be related to an 
enlargement of the aromatic ring system compared to the phenylalanine side chain with the 
consequence of improved interaction with the non-polar solid surface. The most pronounced increase 
in tR was determined for cW3[Fluos]. The enhanced retention on the hydrophobic matrix, which was 
largely based on the reduction in overall charge in both carboxyfluorescein-labeled peptides, related to 
a decrease in antibacterial activity (Table 1, Figure 2). Also, most of the K-containing analogues 
showed slightly higher hydrophobicity than cWFW. Interestingly, cKRK, the only peptide displaying  
a retention time lower than that of the parent peptide, showed pronounced antimicrobial activity  
(Table 1). The strong influence of these particular lysine substitutions on the peptide’s properties is 
reflected in cR2[Cu], cR2[S-Cu] and cR2[NBD] which are also less hydrophobic compared to cWFW. 
Figure 2. Retention times tR of the cyclic hexapeptides. The influence of fluorescent labels 
(dark grey), lysine substitution (light grey) and double modifications (shaded) on interaction 
with the hydrophobic column is shown compared to the parent peptide cWFW (black). 
 
A positive correlation between antimicrobial activity and hydrophobicity/amphipathicity has  
been reported for a large number of helical membrane-permeabilising peptides [24,28]. A high 
hydrophobicity/amphipathicity allows deep peptide penetration and efficient disturbance of the lipid 
matrix of bacterial membranes. Studies with a set of diastereomers of the cyclic β-sheet forming 
gramicidin S analogue GS14 showed a different picture. Here, amphipathicity reflected by tR positively 
correlated with hemolytic activity but was found to be highly disadvantageous for the antimicrobial 
activity of GS14 peptides. A pronounced amphipathic nature was suggested to be undesirable in the 
design of constrained cyclic antimicrobial peptides [25]. Furthermore, investigations on tyrocidines 
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(cyclic decapeptides analogous to GS) also showed that high tR values may reduce the antimicrobial 
activity and a fine amphipathic balance must be maintained in order for the molecules to remain  
active [29,30]. The negative correlation between tR and antimicrobial activity found with our small 
cyclic peptides supports the idea that high hydrophobicity/amphipathicity is also not crucial for their 
antimicrobial action. 
In order to get insight into the influence of chemical modifications on peptide conformation we 
performed CD spectroscopic studies (Figure 3). The spectrum of the parent peptide cWFW in buffer is 
characterized by a negative ellipticity minimum at 202 nm and a shoulder at 220 nm (Figure 3A, solid 
line). The CD spectra at the far UV wavelengths result from the backbone peptide bonds while 
contributions of both, peptide bonds and aromatic side chains, superimpose in the 220–230 nm region. 
The spectrum of cWFW is comparable to that of cyclo-RRWWRF (cRW) [7] which is characterized 
by two β-turns in the backbone and a rather flexible structure in aqueous solution [31]. Coumarin had 
only minor effects on the CD characteristics of the cyclic hexapeptide (Figure 3A, dotted line). 
However, the contribution of an NBD-side chain (cW[NBD]W), Figure 3A, short dash line) is related 
to a reduction of the negative ellipticity values. The intensity decrease and conservation of the 
ellipticity bands and shoulder positions could be associated with changes in backbone flexibility. 
Among the K-containing peptides, cKRK showed the strongest shift in the spectrum with a high 
positive ellipticity below 200 nm (Figure 3B) which points to pronounced changes in backbone 
conformation. These changes are caused by a decrease in the effective hydrophobic surface area as 
reflected by a reduced retention time (Figure 2). In contrast, the other K-analogues are characterized by 
a positive ellipticity maximum at 230 nm, but minor spectral changes in the far UV wavelength range. 
This maximum is likely to result from a different orientation of the aromatic side chains relative to the 
peptide backbone [32], compared to cWFW and cKRK. Analysis of the spectra of cKRK, cW[NBD]W 
(Figure 3B, long dash line and 3A, short dash line) and cR2[NBD] (3A, long dash line) indicates that 
the fluorophore predominates the CD characteristics of the hexapeptide, which combines the polar 
KRK- with the hydrophobic W[NBD]W-cluster. 
Both, detergent micelles and liposomes are often used in spectroscopic studies to mimic the 
anisotropic nature of the lipid matrix of cell membranes. Bound to micelles cWFW adopts an 
amphipathic structure with two β-turns [33]. All the aromatic residues point to the same direction 
establishing the hydrophobic part and the arginine side chains are arranged in a way to interact with  
the polar head groups on the micellar or liposomal surface. Thus, the intensity increase in ellipticity at 
202 nm and the red shift of the shoulder at 220 nm to 225 nm, respectively, imply enhanced backbone 
rigidity and changes in the positioning of the aromatic residues upon partitioning of cWFW into SDS 
micelles and POPG liposomes (Figure 3C, top left column). Interestingly, the four peptides presented 
in Figure 3C with different antimicrobial activities (Table 1) and different CD spectra in buffer showed 
only minor conformational differences when bound to POPG (Figure 3C, dotted lines) and almost 
identical spectral characteristics in interaction with SDS micelles (Figure 3C, dashed lines). These 
observations underline the flexibility of most of the cyclic hexapeptides and their potential to adopt an 
amphipathic structure. Almost identical tR values (Figure 2) point to comparable effective hydrophobic 
surface areas of the four peptides under appropriate conditions (Figure 3C). However, quite different 
antimicrobial activities support the hypothesis that binding to the lipid matrix of the bacterial 
membrane and peptide conformation may not be the major determinants of the biological effect. 
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Figure 3. CD spectra of the cyclic hexapeptides in different solvent systems.  
(A) Lysine-substituted and (B) fluorescent-labeled peptides compared to cWFW in 
phosphate buffer. The effect of membrane-mimicking additives on the structure of selected 
lysine peptides is shown in (C): phosphate buffer (solid lines), 25 mM SDS (dashed lines) 
and 10 mM POPG-SUVs (dotted lines). Peptide concentration was 100 µM. 
 
3.3. Mode of Antimicrobial Action 
In order for the fluorescence-labeled and K-containing derivatives to be applicable in investigations 
on the mode of action of our cyclic hexapeptides, the chemical modifications must have no or only 
little influence on the properties of cWFW. As all peptide analogues used in this study fulfil the 
structural prerequisites for membrane interaction, i.e., high amphipathicity and positive net charge, we 
investigated their potential to permeabilise the bacterial membrane (Figure 4). 
All peptides induced no or only slight membrane permeabilisation when tested against B. subtilis 
(Figure 4, left column). Propidium iodide (PI) influx, due to membrane damage/permeabilisation, was 
slightly higher for cW[Cu]W and cW[S-Cu]W while cR2[Cu] and cR2[NBD] showed results similar to 
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those found for cWFW. Lysine-substituted peptides had minor influence on the membrane integrity of 
Gram-positive as well as Gram-negative cells (Figure 4C,D). In contrast, treatment of E. coli with  
most of the fluorescent-labeled peptides resulted in pronounced membrane disruption with the order 
cW[S-Cu]W > cW[Cu]W > cW[NBD]W > cR2[Cu] (Figure 4B). No E. coli membrane permeabilisation 
could be detected for cR2[NBD]. 
Figure 4. Bacterial membrane permeabilisation determined with flow cytometry using 
propidium iodide (PI). PI influx after incubation with cWFW, fluorescent-labeled and  
K-substituted cyclic hexapeptides was tested into B. subtilis DSM 347 (A,C) and E. coli 
DH5α (B,D) at respective MICs. The antibiotic polymyxin B (5 µM) and the helical  
model peptide KLA-1 (KLALKLALKALKAALKLA-NH2, 5 µM) obtain a high 
membrane permeabilising potential and served as positive control in Gram-negative and 
Gram-positive cells, respectively (solid line) [20,34]. Preparations without peptide were 
used as negative control (dotted line). 
 
As demonstrated for the cyclic hexapeptide cWFW [8], the investigated lysine analogues also 
appear to exert their antibacterial activity via a non-permeabilising mechanism. However, chemical 
modifications in the hydrophobic cluster by introducing fluorophores seem to change the mode of 
peptide interaction with the E. coli membrane. Here, membrane permeabilisation, as monitored by PI 
influx, correlated with peptide hydrophobicity (see Figure 2). An increase in hydrophobicity of this 
class of cyclic peptides and a large number of other antimicrobial sequences was reported to be linked 
to a deeper peptide insertion into and subsequent enhanced disturbance of the lipid matrix of cellular 
membranes [7,24,26]. 
With respect to the investigation of peptide translocation across bacterial membranes, cR2[Cu] and 
cR2[NBD] seem to be the most promising fluorescent-labeled cyclic hexapeptide candidates mimicking 
cWFW. Applying the established strategy for uptake studies in eukaryotic cells, described by Oehlke 
et al. [11], we tested the internalization of cR2[Cu] in comparison to carboxyfluorescein-labeled 
penetratin. Penetratin is a well characterized cell-penetrating peptide [35,36] which has been used for 
transmembrane delivery of a diversity of compounds [37,38]. 
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Figure 5A shows that a large amount of free cyclic peptide remained in the supernatant of the 
incubation solution after 1 h treatment of HeLa S cells, compared to Fluos-penetratin. At the same 
time, after chemical modification of cell surface located peptides, only little cR2[Cu] inaccessible  
to diazotized 2-nitroaniline could be detected, whereas a large amount of penetratin remained 
unmodified (Figure 5B). 
Figure 5. HPLC-based investigation of peptide uptake into HeLa S cells. (A) Amount of 
non-modified, free peptide in the supernatant after 1 h incubation at 37 °C with cR2[Cu] 
(18 nmol) and Fluos-penetratin (9 nmol), (B) non-modified peptide after extensive washing 
of cells and exposure to diazotized 2-nitroaniline. For each peptide, two independent 
experiments were performed in triplicates. 
 
The fraction of translocated penetratin showed to be comparable to the amount of other amphipathic 
peptides internalized into different cell lines [11,34,39], while the cellular uptake of the cyclic 
hexapeptide appeared to be low. The latter can be explained as cR2[Cu] also showed weak hemolytic 
activity, which confirms that this peptide, as the parent cWFW, does not interact well with the neutral 
membranes of eukaryotic cells. These experiments in eukaryotic cells, however, demonstrate the 
general applicability of the lysine- and fluorophore-bearing cyclic hexapeptides for fluorescence- and 
HPLC-based uptake studies. 
4. Conclusions 
Our research on cyclic antimicrobial peptides leads us to the conclusion that minor modifications 
within a small, structurally constrained peptide such as cWFW can result in unpredictable changes in 
antibacterial activity and mode of action. The clustered alignment of polar and hydrophobic amino 
acids in the peptide ring dictates the high level of amphipathicity which is necessary for peptide 
interaction with the bacterial membrane. Although the introduced modifications were chosen on the 
basis of the most suitable properties concerning size, hydrophobicity and net charge, the optimal 
interplay between arginine and the aromatic residues proved to underlie a delicate amphipathic 
balance. This study emphasized the fact that careful consideration needs to be taken when modifying 
small peptides to generate appropriate tools for biophysical and cellular studies especially when adding 
fluorophores. Our attempt to optimize the structure of the cyclic hexapeptides for fluorescence 
microscopy and HPLC-based studies to investigate uptake into bacterial cells resulted in the selection 
of c-KRKW[Dap-NBD]W and c-KRKW[Ala-Coumarin]W. In comparison to the parent peptide, these 
analogues displayed good antimicrobial activity and similar biophysical properties with regard to 
retention behavior and structure in interaction with membrane-mimicking surfaces, respectively.  
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Most important, the modifications conserved the non-membrane permeabilising activity of cWFW 
against bacteria. 
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